Human Reproduction Update, Vol.5, No.3 pp.256-266, 1999
© European Society of Human Reproduction and Embryology 1999; all rights reserved
The role of ovarian volume in reproductive medicine
Bourn Hall Clinic, Bourn, Cambridge, CB3 7TR, UK 0 Corresponding author
Abstract
The human ovary is a dynamic organ which continually changes in size and activity through life, as an integral part of the changes that the female is going through before during and after her reproductive life. Following the rapid increase in the use of transvaginal scan in recent years, the measurement of ovarian volume has become quick, accurate and cost-effective. Ovarian volume is an important tool in the screening, diagnosis and monitoring the treatment of conditions such as polycystic ovarian syndrome, ovarian cancer and adolescent abnormalities. In reproductive medicine, measurement of ovarian volume has a role in the assessment of ovarian reserve and prediction of response to superovulation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K.L.T. Schmidt, C. Y. Andersen, A. Loft, A.G. Byskov, E. Ernst, and A. N. Andersen Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation Hum. Reprod., December 1, 2005; 20(12): 3539 - 3546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Legro, P. Chiu, A. R. Kunselman, C. M. Bentley, W. C. Dodson, and A. Dunaif Polycystic Ovaries Are Common in Women with Hyperandrogenic Chronic Anovulation but Do Not Predict Metabolic or Reproductive Phenotype J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2571 - 2579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lutchman Singh, M. Davies, and R. Chatterjee Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Wallace and T. W. Kelsey Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography Hum. Reprod., July 1, 2004; 19(7): 1612 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Larsen, J. Muller, K. Schmiegelow, C. Rechnitzer, and A. N. Andersen Reduced Ovarian Function in Long-Term Survivors of Radiation- and Chemotherapy-Treated Childhood Cancer J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5307 - 5314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Popovic-Todorovic, A. Loft, H.E. Bredkjaeer, S. Bangsboll, I.K. Nielsen, and A.N. Andersen A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment Hum. Reprod., November 1, 2003; 18(11): 2275 - 2282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Popovic-Todorovic, A. Loft, A. Lindhard, S. Bangsboll, A.M. Andersson, and A.N. Andersen A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram Hum. Reprod., April 1, 2003; 18(4): 781 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lass Assessment of ovarian reserve - is there a role for ovarian biopsy? Hum. Reprod., June 1, 2001; 16(6): 1055 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. I. Sharara and H. D. McClamrock Use of microdose GnRH agonist protocol in women with low ovarian volumes undergoing IVF Hum. Reprod., March 1, 2001; 16(3): 500 - 503. [Abstract] [Full Text] [PDF]
|
|